Search

everythinglearnresearchcommunity

for

Search:↓

DN106212, an extract from a plant, is better at promoting hair growth than other tested substances by affecting hair growth factors and follicle development.

The seed extract of Lepidium sativum L. can potentially treat hair loss, showing effects similar to 5% minoxidil.

Nanotechnology shows promise for better hair loss treatments but needs more research for safety and effectiveness.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Drug repurposing speeds up drug development, saves money, and has led to about a third of new drug approvals.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

Some existing medicines show promise as safe treatments to protect against the side effects of radiation therapy.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Compound 4 is a promising treatment for hair loss with low toxicity.

The combination tablet of finasteride and doxazosin works the same as taking each drug separately.

Finasteride capsules with nanoparticles improve drug delivery, solubility, stability, and effectiveness.

PDRN helps repair tissue and improve wound healing with a high safety profile.

Dienogest combined with ethinylestradiol is a highly effective birth control that improves menstrual symptoms and has manageable side effects.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Nanoemulgel is a better way to deliver drugs through the skin for various conditions.

Eflornithine cream effectively reduces women's unwanted facial hair but hair returns if treatment stops.

Terbinafine quickly builds up in skin and hair, staying effective for over 3 weeks.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Systemic corticosteroids can help treat rapidly spreading vitiligo but require more research for safer use.

New treatment improves male hair loss.

Finasteride effectively treats baldness but may cause sexual side effects.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Psychotropic drugs can help treat skin conditions affected by mental health, but dermatologists must use them carefully due to side effects and patient concerns.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

New antifungal treatments for a children's scalp infection are effective and safe, but it's not decided if they will become the preferred option over the old treatment.

Certain drugs that block specific enzymes can help treat prostate diseases.